Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma

This commentary remarks on a recently published study assessing clinic contact days for patients enrolled in the Canadian Cancer Trials Group LY.12 clinical trial.

Detalles Bibliográficos
Autores principales: Bojanini, Leyla, Gupta, Neel, Khaki, Ali Raza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485298/
https://www.ncbi.nlm.nih.gov/pubmed/37432278
http://dx.doi.org/10.1093/oncolo/oyad204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485298/
https://www.ncbi.nlm.nih.gov/pubmed/37432278
http://dx.doi.org/10.1093/oncolo/oyad204

Ejemplares similares